Orthogen's Products Are Now Sold in Yet Another Major Market

Logo

Springfield, NJ -- (SBWire) -- 01/09/2017 --Orthogen, developers and distributors of the revolutionary dental products NanoGen and DentoGen have begun selling their dental bone graft materials in yet another international market. Orthogen's products have now received the approval from Drug Controller General of India for distribution in India, one of the most populous countries in the World.

With Indian approval in place, NanoGen and DentoGen are now sold in a dozen countries including The United Kingdom, Ukraine, Egypt, Hong Kong, Israel, Peru, Turkey, The United States and many others.

Considered one of the best dental bone graft available, Orthogen's products are widely accredited by top oral surgeons and dentists for both their efficacy and ease of use. The Head of Periodontology at the Government Dental College in Chandigarh, India recently endorsed NanoGen, speaking to its "great results" when treating infrabony defects. India marks another major market in which the company will sell their products, sure to make the difference in more than a few individual's dental care.

The announcement for the sales of NanoGen and DentoGen in another market comes on the heels of the revitalized online store which now features new prices on Orthogen's most popular products. Dental surgeons and instructors are encouraged to visit the recently updated online store to see the company's new prices.

To learn more about Orthogen, read testimonials from the international community or to read about their research and development, interested parties are encouraged to visit the website at http://www.orthogencorp.com/.

About Orthogen, LLC
Originally a division of BioLok International, which is now merged with BioHorizons, Orthogen, LLC was established in 2007 to develop and market next generation bone-grafting products for orthopedic and dental applications. Dr. Sachin Mamidwar serves as CEO of the company whereas Dr. Harold Alexander, previously Director of Orthopedic research at the Hospital for Joint Diseases, New York, serves as the Chairman of the Board. Orthogen offers various products including DentoGen®, NanoGen, collagen membranes, related instruments and sutures for dental applications.

To inquire about the company's products and technologies, please call 1-877-336-8643.

Media Relations Contact

Alex Schwartz
http://www.orthogencorp.com/

View this press release online at: http://rwire.com/757700